GB2479544A - Film forming material to reduce skin irritation due to friction - Google Patents

Film forming material to reduce skin irritation due to friction Download PDF

Info

Publication number
GB2479544A
GB2479544A GB1006121A GB201006121A GB2479544A GB 2479544 A GB2479544 A GB 2479544A GB 1006121 A GB1006121 A GB 1006121A GB 201006121 A GB201006121 A GB 201006121A GB 2479544 A GB2479544 A GB 2479544A
Authority
GB
United Kingdom
Prior art keywords
skin
film forming
forming material
area
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB1006121A
Other versions
GB201006121D0 (en
Inventor
Amit Saha
Steven Sher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brands Worldwide Holdings IP Pty Ltd
Original Assignee
Brands Worldwide Holdings IP Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brands Worldwide Holdings IP Pty Ltd filed Critical Brands Worldwide Holdings IP Pty Ltd
Priority to GB1006121A priority Critical patent/GB2479544A/en
Publication of GB201006121D0 publication Critical patent/GB201006121D0/en
Publication of GB2479544A publication Critical patent/GB2479544A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method of pre-treating an area of skin to reduce the risk of skin irritation comprising the steps of providing a dispensing device containing a film forming material and applying the film forming material to an area of skin, to reduce friction and thereby reduce the risk of acquiring skin irritation that can result from friction against the area of skin to prevent skin blistering and chafing. Preferably, the film forming material comprises an acrylic co-polymer. Preferably the film forming material includes dimethyl ether about 50% w/w acrylic co-polymer about 5% w/w; menthol about 0.05% w/w; n-pentane about 9.450% w/w and ethyl acetate 35.5% w/w. The film forming material may be dissolved in a solvent and may be pressurised such that the film forming material can be spray applied in an aerosol. A use of a film forming material for the preparation of a medicament for pre-treating an area of skin to reduce the risk of acquiring skin irritation is also outlined.

Description

METHOD AND SYSTEM FOR REDUCING SKIN FRICTION
FIELD OF THE INVENTION
The present invention relates to skin treatments and in particular to skin treatments for reducing skin irritation resulting from friction against an area of skin.
The invention has been developed primarily for use as a skin pre-treatment for reducing risk of acquiring skin irritation resulting from friction against an area of skin and will be described hereinafter with reference to this application. However, it will be appreciated that the invention is not limited to this particular field of use.
BACKGROUND OF THE INVENTION
Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of the
common general knowledge in the field.
A common cause of skin irritation, resulting in skin chafing and/or blisters, includes friction. Known devices for treatment of skin against irritation resulting from friction or pressure are in the form of dressings (such as patches and bandages), which are typically applied after irritation has occurred. Dressings can be adapted to slip easily over adjacent materials.
OBJECT OF THE INVENTION
It is an object of the present invention to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useftil alternative.
It is an object of the invention in its preferred form to provide a skin pre-treatment for reducing risk of acquiring chafing and/or a blister.
SUMMARY OF THE INVENTION
According to an aspect of the invention there is provided a method of pre-treating an area of skin to reduce the risk of acquiring skin irritation, the method comprising the steps of: providing a dispensing device containing a film forming material; and applying film forming material to an area of skin, for pre-treating an area of skin to reduce friction and thereby reduce the risk of acquiring skin irritation that can result from friction against the area of skin.
Preferably, the method reduces the risk of acquiring skin chafing. More preferably, the method reduces the risk of acquiring a blister. According to an aspect of the invention there is provided a use of a film forming material for the preparation of a medicament for pre-treating an area of skin to reduce the risk of acquiring skin irritation that can result from friction against the area of skin. Preferably, the use reduces the risk of acquiring skin chafing. More preferably, the use reduces the risk of acquiring a blister.
Preferably, the film forming material is dissolved in a solvent. More preferably, a dispensing device containing the film forming material is pressurized such that the film forming material can be spray applied in an aerosol format.
Preferably, the film forming material includes an acrylic co-polymer. More preferably, the film forming material includes: dimethylether, acrylic co-polymer, menthol, n-pentane, and ethyl acetate. Most preferably, the film forming material includes: dimethylether at about 50 percent w/w; acrylic co-polymer at about 0 5 percent w/w; menthol at about 0.050 percent w/w; n-pentane at about 9.450 percent w!w; and ethyl acetate at about 35.500 percent w/w.
According to an aspect of the invention there is provided a use of a film forming material for the preparation of a medicament for pre-treating an area of skin to reduce the risk of acquiring chafing and/or a blister, as herein described.
BRIEF DESCRIPTION OF THE DRAWINGS
A preferred embodiment of the invention will now be described, by way of example only, with reference to the accompanying drawings in which: FIG. 1 is a schematic view of a dispensing device containing a film forming material according to the invention; and FIG. 2 is a flowchart for a method of applying film forming material according to the invention.
PREFERRED EMBODIMENT OF THE INVENTION
Referring to FIG. 1, a dispensing device 100 contains a film forming material 110. By way of example, the film forming material 110 is in the form of an acrylic co-polymer dissolved in solvent, such as pentane, and pressurized for use in an aerosol form.
Using the aerosol dispensing device 100 to pre-treat an area of skin on a foot 120, a film forming material 110 can be sprayed 112 onto an area of skin 122 for forming a membrane. Preferably, the membrane is water resistant. More preferably, the membrane is air permeable. It will be appreciated that the aerosol dispensing device 100 can pre-treat almost any area of the body to reduce the risk of acquiring chafing and/or a blister.
It will be appreciated that, by way of example only, pre-treatment can cause the formation of a water-resistant air-permeable membrane over an area of skin to provide friction protection and thereby reduce the risk of acquiring chafing and'or a blister.
In an embodiment, the film forming material is in the form of an acrylic co-polymer dissolved in a pentane solvent and pressurized in an aerosol format. By way of example, components of the film forming material can include: Components Percentage Dimethylether 50 % w!w Acrylic co-polymer 5% w/w Menthol 0.050%w/w n-Pentane 9.450 % w/w Ethyl Acetate 35.500 % w/w Similarly, components of the film forming material can include: acrylic acid, dimethylpabamidopropyl laurdimonium tosylate, menthol, and pentane.
It will be appreciated that other film forming materials can be used in accordance with the teaching herein, for pre-treating an area of skin to reduce friction and thereby reduce the risk of acquiring chafing and/or a blister.
Referring to FIG. 2, an example method 200 of applying a film forming material, includes: STEP 210: providing a dispensing device containing a film forming material; and STEP 220: applying a film forming material to an area of skin, for pre-treating an area of skin to reduce friction and thereby reduce the risk of acquiring chafing and/or a blister.
In an embodiment, applying a film forming material comprises spraying a solvent based film forming material onto an area of intact skin for reducing skin friction, which is a common cause of chafing and blisters. It will be appreciated that the method 200 can be both effective and convenient in reducing skin friction.
It will be appreciated that the illustrated method provides a skin pre-treatment for reducing risk of acquiring skin irritation that can result from friction against the area of skin. Preferably, the method reduces the risk of acquiring skin chafing. More preferably, the method reduces the risk of acquiring a blister.
Although the invention has been described with reference to specific examples, it will be appreciated by those skilled in the art that the invention may be embodied in many other forms.
Reference throughout this specification to "one embodiment" or "an embodiment" means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, appearances of the phrases "in one embodiment" or "in an embodiment" in various places throughout this specification are not necessarily all referring to the same embodiment, but may. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner, as would be apparent to one of ordinary skill in the art from this disclosure, in one or more embodiments.
In the claims below and the description herein, any one of the terms comprising, comprised of or which comprises is an open term that means including at least the elements/features that follow, but not excluding others. Thus, the term comprising, when used in the claims, should not be interpreted as being limitative to the means or elements or steps listed thereafter. For example, the scope of the expression a device comprising A and B should not be limited to devices consisting only of elements A and B. Any one of the terms including or which includes or that includes as used herein is also an open term that also means including at least the elements/features that follow the term, but not is excluding others. Thus, including is synonymous with and means comprising.
As used herein, unless otherwise specified the use of the ordinal adjectives "first", "second", "third", etc., to describe a common object, merely indicate that different instances of like objects are being referred to, and are not intended to imply that the objects so described must be in a given sequence, either temporally, spatially, in ranking, or in any other manner.
Similarly it should be appreciated that in the above description of exemplary embodiments of the invention, various features of the invention are sometimes grouped together in a single embodiment, figure, or description thereof for the purpose of streamlining the disclosure and aiding in the understanding of one or more of the various inventive aspects. This method of disclosure, however, is not to be interpreted as reflecting an intention that the claimed invention requires more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed embodiment. Thus, the claims following the Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment of this invention.
Furthermore, while some embodiments described herein include some but not other features included in other embodiments, combinations of features of different embodiments are meant to be within the scope of the invention, and form different embodiments, as would be understood by those in the art. For example, in the following claims, any of the claimed embodiments can be used in any combination.
Furthermore, some of the embodiments are described herein as a method or combination of elements of a method that can be implemented by a processor of a computer system or by other means of carrying out the function. Thus, a processor with the necessary instructions for carrying out such a method or element of a method forms a means for carrying out the method or element of a method. Furthermore, an element described herein of an apparatus embodiment is an example of a means for carrying out the function performed by the element for the purpose of carrying out the invention.
In the description provided herein, numerous specific details are set forth. However, it is understood that embodiments of the invention may be practised without these specific details. In other instances, well-known methods, structures and techniques have not been shown in detail in order not to obscure an understanding of this description.
Thus, while there has been described what are believed to be the preferred embodiments of the invention, those skilled in the art will recognize that other and further modifications may be made thereto without departing from the spirit of the invention, and it is intended to claim all such changes and modifications as fall within the scope of the invention. For example, any formulas given above are merely representative of procedures that may be used. Functionality may be added or deleted from the block diagrams and operations may be interchanged among functional blocks. Steps may be added or deleted to methods described within the scope of the present invention.

Claims (18)

  1. CLAIMS: 1. A method of pre-treating an area of skin to reduce the risk of acquiring skin irritation, the method comprising the steps of: providing a dispensing device containing a film forming material; and applying a film forming material to an area of skin, for pre-treating an area of skin to reduce friction and thereby reduce the risk of acquiring skin irritation that can result from friction against the area of skin.
  2. 2. The method according to claim 1, wherein the film fomiing material includes an acrylic co-polymer.
  3. 3. The method according to claim 1, wherein the film fomiing material includes: dimethylether, acrylic co-polymer, menthol, n-pentane, and ethyl acetate.
  4. 4. The method according to claim 1, wherein the film fomiing material includes: dimethylether at about 50 percent w/w; acrylic co-polymer at about 5 percent w/w; menthol at about 0.050 percent w/w; n-pentane at about 9.450 percent w/w; and ethyl acetate at about 35.500 percent w/w.
  5. 5. The method according to any one of the preceding claims, wherein the film forming material is dissolved in a solvent.
  6. 6. The method according to claim 5, wherein the dispensing device is pressurized such that the film forming material can be spray applied in an aerosol format.
  7. 7. The method according to any one of the preceding claims, wherein the film forming material applied to the area of skin reduces friction to thereby reduce risk of acquiring skin chafing to that area of skin.
  8. 8. The method according to any one of claims 1 to 6, wherein the film forming material applied to the area of skin reduces friction to thereby reduce risk of acquiring a skin blister to that area of skin.
  9. 9. A method of pre-treating an area of skin to rcduce the risk of acquiring skin iffitation, substantially as herein described with reference to the accompanying drawings.
  10. 10. A use of a film forming material for the preparation of a medicament for pre-treating an area of skin to reduce the risk of acquiring skin initation.
  11. 11. The use of a film forming material according to claim 10, wherein the film forming material includes an acrylic co-polymer.
  12. 12. The use of a film forming material according to claim 10 or 11, wherein the film forming material is dissolved in a solvent.
  13. 13. The use of a film forming material according to claim 12, wherein a dispensing device is pressurized such that the film forming material can be spray applied in an aerosol format.
  14. 14. The use of a film forming material according to any one of claims 10 to 13, wherein the film forming material includes: dimethylether, acrylic co-polymer, menthol, n-pentane, and ethyl acetate.
  15. 15.The use of a film forming material according to any one of claims 10 to 13, wherein the film forming material includes: dimethylether at about 50 percent w/w; acrylic co-polymer at about 5 percent w/w; menthol at about 0.050 percent w/w; n-pentane at about 9.450 percent w/w; and ethyl acetate at about 35.500 percent w/w.
  16. 16. The use of a film forming material according to any one of claims 10 to 15, wherein the film forming material applied to the area of skin reduces friction to thereby reduce risk of acquiring skin chafing to that area of skin.
  17. 17. The use of a film forming material according to any one of claims 10 to 15, wherein the film forming material applied to the area of skin reduces friction to thereby reduce risk of acquiring a skin blister to that area of skin.
  18. 18. The use of a film forming material for the preparation of a medicament for pre-treating an area of skin to reduce the risk of acquiring skin irritation, substantially as herein described with reference to the accompanying drawings.
GB1006121A 2010-04-13 2010-04-13 Film forming material to reduce skin irritation due to friction Withdrawn GB2479544A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1006121A GB2479544A (en) 2010-04-13 2010-04-13 Film forming material to reduce skin irritation due to friction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1006121A GB2479544A (en) 2010-04-13 2010-04-13 Film forming material to reduce skin irritation due to friction

Publications (2)

Publication Number Publication Date
GB201006121D0 GB201006121D0 (en) 2010-05-26
GB2479544A true GB2479544A (en) 2011-10-19

Family

ID=42236213

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1006121A Withdrawn GB2479544A (en) 2010-04-13 2010-04-13 Film forming material to reduce skin irritation due to friction

Country Status (1)

Country Link
GB (1) GB2479544A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037682A1 (en) * 2012-09-05 2014-03-13 32 Degrees Limited Nail polish drying method and product therefor

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005289884A (en) * 2004-03-31 2005-10-20 Kusanoha Keshohin:Kk Lubricating lotion
WO2007070643A2 (en) * 2005-12-14 2007-06-21 Zars, Inc. Compositions and methods for treating dermatological conditions
US20090053158A1 (en) * 2007-08-21 2009-02-26 Eric Spengler Pre-Shave Preparation With Enhanced Lubricity
EP2080509A1 (en) * 2008-01-18 2009-07-22 McNeil-PPC, Inc. Lubricious, non-tacky personal lubricant
DE102008019303A1 (en) * 2008-04-16 2009-10-22 Hegedüs, Viktor Skin protection composition, useful e.g. as agent for preventing or treating callus and blisters, comprises a polymerization mixture, which is hardenable under the influence of light, e.g. polyester(meth)acrylate or polyolacrylate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005289884A (en) * 2004-03-31 2005-10-20 Kusanoha Keshohin:Kk Lubricating lotion
WO2007070643A2 (en) * 2005-12-14 2007-06-21 Zars, Inc. Compositions and methods for treating dermatological conditions
US20090053158A1 (en) * 2007-08-21 2009-02-26 Eric Spengler Pre-Shave Preparation With Enhanced Lubricity
EP2080509A1 (en) * 2008-01-18 2009-07-22 McNeil-PPC, Inc. Lubricious, non-tacky personal lubricant
DE102008019303A1 (en) * 2008-04-16 2009-10-22 Hegedüs, Viktor Skin protection composition, useful e.g. as agent for preventing or treating callus and blisters, comprises a polymerization mixture, which is hardenable under the influence of light, e.g. polyester(meth)acrylate or polyolacrylate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
http://solutions.3m.co.uk/wps/portal/3M/en_GB/Cavilon/skin-care/products/no-sting-barrier-film/ Accessed 14 July 2011 *
http://www.backpackinglight.com/cgi-bin/backpackinglight/body_glide_45_anti_blister_stick.html Accessed 14 July 2011 *
http://www.bravesoldier.com/friction-zone.php Accessed 14 July 2011 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037682A1 (en) * 2012-09-05 2014-03-13 32 Degrees Limited Nail polish drying method and product therefor

Also Published As

Publication number Publication date
GB201006121D0 (en) 2010-05-26

Similar Documents

Publication Publication Date Title
CN102573723B (en) Adhesive patch
KR100895188B1 (en) Transdermal therapeutic system tts with fentanyl as active ingredient
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
MX347195B (en) Transdermal drug delivery system and method of using the same.
WO2010008893A3 (en) Anchor systems and methods
RS54173B1 (en) Transdermal therapeutic system for application of an agent
WO2011029948A3 (en) Transdermal therapeutic system for administering fentanyl or an analogue thereof
JP4616542B2 (en) Ointment application member and ointment patch using the same
IL273329A (en) Modulation of heparin-binding epidermal growth factor activity for tympanic membrane healing
KR20170120181A (en) Adhesive plaster
CN108883078B (en) Adhesive patch having abuse-preventing property
GB2479544A (en) Film forming material to reduce skin irritation due to friction
JPH11504643A (en) Transdermal therapeutic system for testosterone administration (TTS)
WO2012111996A3 (en) Transdermal delivery system containing galantamine or salts thereof
ES2887200T3 (en) adhesive patch
US20110250147A1 (en) Method and System for Reducing Skin Friction
WO2009007334A3 (en) Transdermal therapeutic systems which contain the substance anastrozole
TWI717323B (en) External composition containing S-flubeprofen
CL2020001738A1 (en) Percutaneous absorption preparation for the treatment of dementia containing donepezil.
JP6193846B2 (en) pack
JP4943160B2 (en) Dosage forms based on cross-linked hydrophilic polymers
MX2015010967A (en) Transdermal formulations of laquinimod.
JP2016513665A5 (en)
CN103156730A (en) Heterogeneity decellularized cell dermis matrix wound protecting system
EP3031459B1 (en) Beraprost-containing patch

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)